Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Qingyuan Qu, Lingyan Zhang, Chao Xue, Xueling Ge, PhD, Xiao Lv, Kang Lu, MD PhD, Xin Wang, MD PhD, Yujie Jiang, MD

Blood (2019) 134 (Supplement_1): 5339.

https://doi.org/10.1182/blood-2019-129629

Published: 2019

Journal Articles

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

Henry Idrobo, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Sally Rose Paredes, MD, Ivan Perdomo, MD, Pilar León, MD, Christine Rojas, MD, Virginia Abello, MD, Monica Osuna Pérez, MD, Juan Esteban Garcia-Robledo, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2019) 134 (Supplement_1): 4047.

https://doi.org/10.1182/blood-2019-123588

Published: 2019

Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Blood (2019) 134 (Supplement_1): 4121.

https://doi.org/10.1182/blood-2019-127479

Published: 2019

Journal Articles

Dysregulation of Hemostatic Biomarkers, Inflammatory Biomarkers, and Alteration of Cellular Indices As Predictors of Adverse Outcomes in Pulmonary Embolism Patients

Iman Darwish, Yevgeniy Brailovsky, DO, Amir Darki, MD MSc, Debra Hoppensteadt, PhD, Brett Slajus, Emily Bontekoe, Frank De Stefano, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 2408.

https://doi.org/10.1182/blood-2019-126876

Published: 2019

Journal Articles

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Brett Slajus, Yevgeniy Brailovsky, DO, Trung Phan, Iman Darwish, Jawed Fareed, PhD, Amir Darki, MD MSc

Blood (2019) 134 (Supplement_1): 2103.

https://doi.org/10.1182/blood-2019-127425

Published: 2019

Journal Articles

Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR) and Risk of Thromboembolism in Patients with Lymphoma

Darko Antic, PhD, Natasa Milic, Vladimir Otasevic, Tanja Virijevic Salak, Vladislava Djurasinovic, Vojin Vukovic, Kristina Tomic, Biljana Mihaljevic, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 3649.

https://doi.org/10.1182/blood-2019-130073

Published: 2019

Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Blood (2019) 134 (Supplement_1): 1613.

https://doi.org/10.1182/blood-2019-123841

Published: 2019

Journal Articles

Real-World Evidence of the Use of Carfilzomib and Dexamethasone (Kd) By Lenalidomide-Refractory Status: An Interim Analysis from a Prospective Observational Study

Xavier Leleu, MD PhD, Jo Caers, MD PhD, Barbara Gamberi, MD, Maaike Söhne, MD, Sonja Heibl, MD, Florence Suzan, MD, Abeera Mohammad, Sally Wetten, Evangelos Terpos, MD

Blood (2019) 134 (Supplement_1): 5578.

https://doi.org/10.1182/blood-2019-122938

Published: 2019

Journal Articles

Does Transfusion of Red Blood Cells Impact Germline Genetic Test Results?

Margaret Diguardo, MD, Scott Hammel, Kate Heaser, Victor Mahaffey, Christopher Hofich, Sarah Kester, Sarah Kerr, MD, Jennifer L. Oliveira, MD, Eapen K. Jacob, MD, Ann Moyer, MD

Blood (2019) 134 (Supplement_1): 3698.

https://doi.org/10.1182/blood-2019-128576

Published: 2019

Journal Articles

Prognostic Role of Neutrophil to Lymphocyte Ratio (NLR) in Myelofibrosis Patients Treated with Ruxolitinib: A Multi-Center Experience

Blood (2018) 132 (Supplement 1): 4303.

https://doi.org/10.1182/blood-2018-99-116418

Published: 2018

Journal Articles

Validation of the Nccn-Ipi for Diffuse Large B-Cell Lymphoma in Latin American Patients: A Study from the Latin-American Group of Lymphomas (GELL)

Brady E. Beltrán, MD, Victoria Otero, MD, Marialejandra Torres Viera, MD, Camila Peña, MD, Myriam Lucía Rodriguez, MD, Gabriel Borelli, MD, Teodoro Chisesi, Fabiola Valvert Gamboa, MD, Abel Berrios, MD, Gregorio Ignacio, MD, Carlos Sérgio Chiattone, MD, Sally Paredes, MD, Denisse A. Castro, MD, Maria Elena Cabrera, Raul Gabus, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 5395.

https://doi.org/10.1182/blood-2018-99-113214

Published: 2018

Journal Articles

Pre-Treatment Derived Neutrophil to Lymphocyte Ratio As a Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma

Xiangxiang Zhou, MD, Lingyan Zhang, MD, Ying Li, MD, Xiaosheng Fang, PhD, Xiao Lv, PhD, Kang Lu, PhD, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 5307.

https://doi.org/10.1182/blood-2018-99-115907

Published: 2018

Journal Articles

Does Neutrophil to Lymphocyte Ratio (NLR) Predict the Prognosis of Diffuse Large B-Cell Lymphoma?

Aya Nakaya, MD PhD, Shinya Fujita, MD PhD, Atsushi Satake, MD PhD, Takahisa Nakanishi, MD PhD, Yoshiko Azuma, MD, Yukie Tsubokura, MD, Ryo Saito, MD, Akiko Konishi, MD, Masaaki Hotta, MD, Hideaki Yoshimura, MD, Kazuyoshi Ishii, MD MPH, PhD, Tomoki Ito, MD PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 5402.

https://doi.org/10.1182/blood-2018-99-117823

Published: 2018

Journal Articles

RDW Is a Prognostic Marker for Patients with Aggressive Peripheral T-Cell Lymphoma

Brady E. Beltrán, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 5364.

https://doi.org/10.1182/blood-2018-99-113236

Published: 2018

Journal Articles

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Guru Subramanian Guru Murthy, MBBS, Aric C. Hall, MD, Ehab L. Atallah, MD, Ryan J. Mattison, MD

Blood (2018) 132 (Supplement 1): 5246.

https://doi.org/10.1182/blood-2018-99-112204

Published: 2018

Journal Articles

A Study about the Relationship between Thrombotic Events and Peripheral Neutrophil-to-Lymphocyte Ratio in Patients with Newly Diagnosed Essential Thrombocythemia

Hai Cheng, MD, Dian Zhou, graduate student, Jiang Cao, MD PhD, Wei Chen, Kunming Qi, Kailin Xu, MD, PhD, Jianlin Qiao, PhD

Blood (2018) 132 (Supplement 1): 5465.

https://doi.org/10.1182/blood-2018-99-112785

Published: 2018

Journal Articles

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Erica Sparkenbaugh, PhD BS, Kathryn Wilson, BS, Malgorzata Kasztan, PhD, David M. Pollock, PhD, Keith R. McCrae, MD, Rafal Pawlinski, PhD

Blood (2018) 132 (Supplement 1): 268.

https://doi.org/10.1182/blood-2018-99-116526

Published: 2018

Journal Articles

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Andrea Sitlinger, MD, Dana P Thompson, PhD, Michael A Deal, BS, Erwin Garcia, PhD, Tiffany Stewart, BS, Eross Guadalupe, BS, J. Brice Weinberg, MD, David A Bartlett, PhD, Danielle M. Brander, MD

Blood (2018) 132 (Supplement 1): 5540.

https://doi.org/10.1182/blood-2018-99-117736

Published: 2018

Journal Articles

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Blood (2018) 132 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2018-99-115346

Published: 2018

Journal Articles

Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR) in Relapsed/Refractory Aggressive Lymphoma Salvage Chemotherapy — Analysis of Canadian Cancer Trials Group (CCTG) ly.10 Trial

Mina Dehghani Mohammadabadi, MD, Annette E Hay, Lois E. Shepherd, Michael Crump, MD, Bingshu E. Chen, Tara Baetz, MD

Blood (2018) 132 (Supplement 1): 2980.

https://doi.org/10.1182/blood-2018-99-116316

Published: 2018

NARROW

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Dysregulation of Hemostatic Biomarkers, Inflammatory Biomarkers, and Alteration of Cellular Indices As Predictors of Adverse Outcomes in Pulmonary Embolism Patients

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR) and Risk of Thromboembolism in Patients with Lymphoma

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Real-World Evidence of the Use of Carfilzomib and Dexamethasone (Kd) By Lenalidomide-Refractory Status: An Interim Analysis from a Prospective Observational Study

Does Transfusion of Red Blood Cells Impact Germline Genetic Test Results?

Prognostic Role of Neutrophil to Lymphocyte Ratio (NLR) in Myelofibrosis Patients Treated with Ruxolitinib: A Multi-Center Experience

Validation of the Nccn-Ipi for Diffuse Large B-Cell Lymphoma in Latin American Patients: A Study from the Latin-American Group of Lymphomas (GELL)

Pre-Treatment Derived Neutrophil to Lymphocyte Ratio As a Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma

Does Neutrophil to Lymphocyte Ratio (NLR) Predict the Prognosis of Diffuse Large B-Cell Lymphoma?

RDW Is a Prognostic Marker for Patients with Aggressive Peripheral T-Cell Lymphoma

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

A Study about the Relationship between Thrombotic Events and Peripheral Neutrophil-to-Lymphocyte Ratio in Patients with Newly Diagnosed Essential Thrombocythemia

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR) in Relapsed/Refractory Aggressive Lymphoma Salvage Chemotherapy — Analysis of Canadian Cancer Trials Group (CCTG) ly.10 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only